Niramai

We, at NIRAMAI, are developing a novel software to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable cancer screening tool that can be operated by a simple clinician. Unlike mammography, our imaging method is radiation free, non-touch, not painful and works for women of all ages. The core technology of our solution is an artificial intelligence led diagnostic platform that uses patented thermal image processing and machine learning algorithms for reliable and accurate breast cancer screening. This unique solution can be used as a cancer diagnosis test in hospitals, used for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas.

59.2
59.2
NaN
NaN
NaN
NaN
Links
Valuation
$
Funding
$ 7.05 M
Statistics
NA

We, at NIRAMAI, are developing a novel software to detect breast cancer at a much earlier stage than traditional methods or self-examination. Our solution is a low cost, accurate, automated, portable cancer screening tool that can be operated by a simple clinician. Unlike mammography, our imaging method is radiation free, non-touch, not painful and works for women of all ages. The core technology of our solution is an artificial intelligence led diagnostic platform that uses patented thermal image processing and machine learning algorithms for reliable and accurate breast cancer screening. This unique solution can be used as a cancer diagnosis test in hospitals, used for regular preventive health checkups, and also for large scale screening in rural and semi-urban areas.

Overview
Merck KGaAMerck KGaAMerck KGaAMerck KGaAMerck KGaA 
View All
0and0